[Critical role of activating immune receptor DNAM-1 in the development of acute GVHD].
Minoru
M
Kanaya
Tsukasa
T
Nabekura
Kazuko
K
Shibuya
Akira
A
Shibuya
D000208:Acute Disease; D000818:Animals; D000906:Antibodies / Q000008:administration & dosage / Q000627:therapeutic use; D000945:Antigens, Differentiation, T-Lymphocyte / Q000737:chemistry / Q000276:immunology*; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D018450:Disease Progression; D006086:Graft vs Host Disease / Q000235:genetics / Q000276:immunology* / Q000517:prevention & control / Q000628:therapy; D006801:Humans; D051379:Mice; D058990:Molecular Targeted Therapy; D000098862:T Lineage-Specific Activation Antigen 1
D000906:Antibodies; D000945:Antigens, Differentiation, T-Lymphocyte; D000098862:T Lineage-Specific Activation Antigen 1